Skip to main content

Hearing Loss and Its Types


Hearing loss is also known as hearing impairment which is defined as the partial or total inability to hear in a person. This medical condition can occur in one or both ears. Hearing loss can be temporary or permanent, depending on the causative agent of the medical complication. There are different factors such as genetics, aging, exposure to high decibel (dB) of sound, chronic infections, birth complications, trauma, toxins, or occupational hazards. There are certain infections which occur during pregnancy such as syphilis and rubella, which can result in birth complications and hearing loss in child. Based on the degree of hearing loss, the hearing loss is classified as mild (25-40 dB), moderate (41-55 dB), moderate-severe (56-70 dB), severe (71-90 dB), and profound (greater than 90 dB). Hearing loss is also categorized into- conductive, sensorineural, mixed, and auditory neuropathy spectrum disorder, based on the conduction of sound.

Get a copy of the report on Hearing Aids Market by BIS Research

Hearing Aids Market


Type of Hearing Loss
§  Conductive Hearing Loss: This type of hearing loss is caused by an obstruction in the outer or middle ear for the conduction of sound. This type of hearing loss can be treated with the help of medication or surgical procedure.
§  Sensorineural Hearing Loss: This type of hearing loss is caused by an obstruction in the conduction of sound in the inner ear or failure in the hearing nerve.
§  Mixed Hearing Loss: This type of hearing loss is a combination of conductive and sensorineural hearing loss in a patient.

Auditory Neuropathy Spectrum Disorder: This type of hearing loss occurs when there is a conduction damage in the inner ear, or the hearing nerve and the brain is unable to interpret the sound.

According to the Centres for Disease Control and Prevention (CDC), hearing loss can also be classified as follows:
§  Unilateral or Bilateral: Unilateral type of hearing loss caused in one ear, whereas bilateral hearing loss occurs in both ears.
§  Pre-lingual or Post-lingual: Pre-lingual type of hearing loss caused in a person before he/she learned to talk, whereas post-lingual type of hearing loss is acquired in a patient after he/she learnt to talk.
§  Symmetrical or Asymmetrical: Symmetrical hearing loss is a type of hearing loss where the intensity of loss is same in both ears, whereas in asymmetrical hearing loss the intensity of sound conduction is different in each ear.
§  Progressive or Sudden: Progressive hearing loss is a type of hearing loss which can worsen over a period, whereas sudden hearing loss occurs abruptly due to various factors such as genetic, occupational hazards or exposure to high dB of sound.
§  Fluctuating or Stable: Fluctuating hearing loss is a type of hearing loss which is irregular in a patient whereas the hearing loss which is stable during a period is known as stable hearing loss.
§  Congenital or Acquired/Delayed Onset: Congenital type of hearing loss occurs at the time of birth, whereas acquired or delayed onset of hearing loss occurs later in the lifetime of a patient.

For the treatment of hearing loss, hearing aid devices are used. Hearing aid is a small medical device used for the amplification of sound in a partially deaf or completely hearing-impaired patient. The device is designed to improve a person’s hearing ability. There are different variants of hearing aid devices used for curing hearing loss in individual of all age groups. The types of hearing aid devices have been discussed further in the report, along with the factors influencing the market demand for these devices.

Comments

Popular posts from this blog

Chatbots Increasing Efficiency in Healthcare Market

Chatbots are one of the prominent technologies currently being integrated into the healthcare system. The chatbots are not considered as the SaMD (software as medical device) as they do not participate in clinical decision-making process, rather, they act as the personal healthcare assistant as well as the trainer for its users. Click Here To Get Detailed Description of  Chatbots in Healthcare Market The usage of chatbots in the healthcare has gained popularity since 2013, when Babylon Health, the first healthcare chatbot company of the U.K. was launched. The company offered symptom checker chatbot and has started using the same chatbot as a health checker as well. The industry comprises the bot developers, platform providers, content providers, and the interface providers. Since there are no regulatory bodies such as FDA and MHRA directly governing the usage of chatbots, launching the chatbot is convenient for the developers. New start-ups are coming up wit...

Wireless Charging Technology – Analyzing the Market Drivers and Restraints

Wireless charging technology eliminates the use of wires to power devices and enables a device to be charged automatically when placed near a transmitter. The wireless charging technology is however, not new in the world of technology, rather, has been in existence since the late 1800s. With the incorporation of the technology in smartphones, it has been experiencing a massive boost in popularity. Request the Sample @  https://bisresearch.com/requestsample?id=645&type=download According to the latest market intelligence report by BIS Research titled “ Global Wireless Charging Market - Analysis and Forecast (2018-2023) ,” the market was valued at $2.58 billion in 2017 and is projected to grow at a CAGR of 40.97%, during the forecast period and reach $20.97 billion by 2023.  The market is estimated to witness the highest growth in the Asia-Pacific (APAC) region during the forecast period (2018-2023). The wireless charging technology is not only limited to the sm...

Neoantigens Vaccines Can Bridge the Treatment Gap by Training the Immune System to Recognize Tumor Cells

As per BIS Research analysis, the neoantigen cancer vaccine market is projected to reach $1826.1 million by 2030 from $227.1 million in 2023, at a CAGR of 34.69%. Growth in this market is expected to be driven by the ever-rising patient pool of different cancers and significant investment in research for development for cancer neoantigen vaccines to fill in the current treatment gaps. However, there are significant challenges that are restraining the market growth. These challenges include the high cost of therapy (personalized cancer vaccines), manufacturing complications, and lack of therapeutic biomarkers and assays. The market is still at the nascent phase with more than two-thirds of the neovaccines in the early stages of development. However, few neovaccines companies such as OSE Immunotherapeutics, Immunovative Therapeutics, Medigene, and Roche have positioned themselves to launch their neovaccines in the market within the upcoming years. That being said, the neovacc...